D. Rittirsch, M. A. Flierl, and P. A. Ward, Harmful molecular mechanisms in sepsis, Nat Rev Immunol, vol.8, pp.776-87, 2008.

J. C. Kagan, Defining the subcellular sites of innate immune signal transduction, Trends Immunol, vol.33, pp.442-450, 2012.

J. Yan, S. Li, and S. Li, The role of the liver in sepsis, Int Rev Immunol, vol.33, pp.498-510, 2013.

T. Gustot, F. Durand, D. Lebrec, J. L. Vincent, and R. Moreau, Severe sepsis in cirrhosis, Hepatology, vol.50, pp.2022-2055, 2009.

R. Silverstein, galactosamine lethality model: scope and limitations, J Endotoxin Res, vol.10, issue.3, pp.147-62, 2004.

A. Mignon, N. Rouquet, M. Fabre, S. Martin, J. C. Pagès et al., LPS challenge in d-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock, Am J Respir Crit Care Med, vol.159, pp.1308-1323, 1999.

J. Rao, C. Zhang, P. Wang, L. Lu, X. Qian et al., C/EBP homologous protein (CHOP) contributes to hepatocyte death via the promotion of ERO1? signalling in acute liver failure, Biochem J, vol.466, pp.369-78, 2015.

H. Malhi and R. J. Kaufman, Endoplasmic reticulum stress in liver disease, J Hepatol, vol.54, pp.795-809, 2011.

N. Chen, N. Nishio, S. Ito, Y. Tanaka, Y. Sun et al., Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model, Cancer Immunol Immunother, vol.64, pp.777-89, 2015.

Y. Inaba, T. Furutani, K. Kimura, H. Watanabe, S. Haga et al., Growth arrest and DNA damage-inducible 34 regulates liver regeneration in hepatic steatosis in mice, Hepatology, vol.61, pp.1343-56, 2015.

G. Clavarino, N. Cláudio, T. Couderc, A. Dalet, J. D. Camosseto et al., Induction of GADD34 is necessary for dsRNA-dependent interferon-? production and participates in the control of chikungunya virus infection, PLoS Pathog, vol.8, issue.5, p.1002708, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00964879

G. Clavarino, N. Cláudio, A. Dalet, S. Terawaki, T. Couderc et al., Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic:polycytidylic acid-stimulated dendritic cells, Proc Natl Acad Sci U S A, vol.109, pp.3006-3017, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00685819

A. Dalet, R. J. Argüello, A. Combes, L. Spinelli, S. Jaeger et al., Protein synthesis inhibition and GADD34 control IFN-? heterogeneous expression in response to dsRNA, EMBO J, vol.36, issue.6, pp.761-82, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01476255

P. Tsaytler, H. P. Harding, R. D. Bertolotti, and A. , Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis, Science, vol.332, pp.91-95, 2011.

C. Neuber, J. Uebeler, T. Schulze, H. Sotoud, A. El-armouche et al., Guanabenz interferes with ER stress and exerts protective effects in cardiac myocytes, PLoS One, vol.9, issue.6, p.98893, 2014.

S. S. Ohri, A. Mullins, M. Hetman, and S. R. Whittemore, Inhibition of GADD34, the stress-inducible regulatory subunit of the endoplasmic reticulum stress response, does not enhance functional recovery after spinal cord injury, PLoS One, vol.9, issue.11, p.109703, 2014.

S. W. Way, J. R. Podojil, B. L. Clayton, A. Zaremba, T. L. Collins et al., Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic, Nat Commun, vol.6, p.6532, 2015.

B. Holmes, R. N. Brogden, R. C. Heel, T. M. Speight, and G. S. Avery, Guanabenz: a review of its pharmacodynamic properties and therapeutic efficacy in hypertension, Drugs, vol.26, pp.212-241, 1983.

B. Siegmund, K. C. Lear-kaul, R. Faggioni, and G. Fantuzzi, Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis, Eur J Immunol, vol.32, pp.552-60, 2002.

N. Cláudio, A. Dalet, E. Gatti, and P. Pierre, Mapping the crossroads of immune activation and cellular stress response pathways, EMBO J, vol.32, pp.1214-1238, 2013.

M. N. Lee, C. Ye, A. C. Villani, T. Raj, W. Li et al., Common genetic variants modulate pathogen-sensing responses in human dendritic cells, Science, vol.343, p.1246980, 2014.

H. Negishi, H. Yanai, A. Nakajima, R. Koshiba, K. Atarashi et al., Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses, Nat Immunol, vol.13, pp.659-66, 2012.

S. Rutz and W. Ouyang, Regulation of interleukin-10 expression, Adv Exp Med Biol, vol.941, pp.89-116, 2016.

S. Akira, S. Akira, S. Uematsu, S. Uematsu, O. Takeuchi et al., Pathogen recognition and innate immunity, Cell, vol.124, pp.783-801, 2006.

J. C. Kagan, Signaling organelles of the innate immune system, Cell, vol.151, pp.1168-78, 2012.

. Ruffolo-rr, A. J. Nichols, J. M. Stadel, and P. J. Hieble, Structure and function of a-adrenoceptors, Pharmacol Rev, vol.43, p.475, 1991.

T. Avni, A. Lador, S. Lev, L. Leibovici, M. Paul et al., Vasopressors for the treatment of septic shock: systematic review and meta-analysis, PLoS One, vol.10, issue.8, p.129305, 2015.

D. C. Angus and T. Van-der-poll, Severe sepsis and septic shock, N Engl J Med, vol.369, pp.840-51, 2013.

L. Wang, B. Popko, E. Tixier, and R. P. Roos, Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis, Neurobiol Dis, vol.71, pp.317-341, 2014.
DOI : 10.1016/j.nbd.2014.08.010

URL : http://europepmc.org/articles/pmc4179984?pdf=render

S. W. Way, B. Popko, B. Popko, and S. W. Way, Harnessing the integrated stress response for the treatment of multiple sclerosis, Lancet Neurol, vol.15, pp.434-477, 2016.

W. J. Wiersinga, S. J. Leopold, D. R. Cranendonk, and T. Van-der-poll, Host innate immune responses to sepsis, Virulence, vol.5, pp.36-44, 2014.
DOI : 10.4161/viru.25436

URL : https://www.tandfonline.com/doi/pdf/10.4161/viru.25436?needAccess=true

S. Ito, Y. Tanaka, R. Oshino, S. Okado, M. Hori et al., GADD34 suppresses lipopolysaccharide-induced sepsis and tissue injury through the regulation of macrophage activation, Cell Death Dis, vol.7, p.2219, 2016.

I. Das, A. Krzyzosiak, K. Schneider, L. Wrabetz, M. D. Antonio et al., Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit, Science, vol.348, pp.229-261, 2015.